CGN Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
30,296
+592
| +2% | +$46.9K | 0.21% | 100 |
|
|
2025
Q1 | $2.67M | Buy |
29,704
+2,735
| +10% | +$245K | 0.26% | 88 |
|
|
2024
Q4 | $2.68M | Buy |
26,969
+102
| +0.4% | +$10.1K | 0.26% | 85 |
|
|
2024
Q3 | $3.05M | Buy |
26,867
+321
| +1% | +$36.5K | 0.31% | 80 |
|
|
2024
Q2 | $3.29M | Sell |
26,546
-74
| -0.3% | -$9.16K | 0.38% | 63 |
|
|
2024
Q1 | $3.51M | Buy |
26,620
+851
| +3% | +$112K | 0.45% | 47 |
|
|
2023
Q4 | $2.81M | Sell |
25,769
-1,321
| -5% | -$144K | 0.39% | 68 |
|
|
2023
Q3 | $2.79M | Buy |
27,090
+1,241
| +5% | +$128K | 0.38% | 67 |
|
|
2023
Q2 | $2.98M | Buy |
25,849
+2,248
| +10% | +$259K | 0.43% | 62 |
|
|
2023
Q1 | $2.51M | Buy |
23,601
+1,635
| +7% | +$174K | 0.4% | 68 |
|
|
2022
Q4 | $2.44M | Buy |
21,966
+7,125
| +48% | +$791K | 0.43% | 59 |
|
|
2022
Q3 | $1.28M | Buy |
14,841
+2,933
| +25% | +$253K | 0.32% | 88 |
|
|
2022
Q2 | $1.09M | Buy |
+11,908
| New | +$1.09M | 0.31% | 84 |
|
|
2021
Q3 | – | Sell |
-3,781
| Closed | -$294K | – | 203 |
|
|
2021
Q2 | $294K | Buy |
3,781
+184
| +5% | +$14.3K | 0.09% | 173 |
|
|
2021
Q1 | $265K | Hold |
3,597
| – | – | 0.1% | 173 |
|
|
2020
Q4 | $281K | Buy |
+3,597
| New | +$281K | 0.11% | 164 |
|